These cholesterol level charts will show you what's normal for every age and gender. Plus, a few tips for staying within a ...

April 10, 2025 — The National Lipid Association (NLA) and the American Geriatrics Society (AGS) have released a Joint Scientific Statement focused on the management of hypercholesterolemia in adults ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...

Statins are considered safe and effective, but they may not be right for everyone to lower cholesterol.

Longer-term exposure to and adoption of US dietary and lifestyle habits may contribute to shift in cardiovascular risk.

In a global trial of over 2,500 patients, obicetrapib dramatically reduced LDL cholesterol levels when added to standard lipid-lowering therapy, offering new hope for those at highest cardiovascular ...

Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study Enlicitide is the ...

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody ...